These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2416749)

  • 1. Human plasma prekallikrein. Immunoaffinity purification and activation to alpha- and beta-kallikrein.
    Burger D; Schleuning WD; Schapira M
    J Biol Chem; 1986 Jan; 261(1):324-7. PubMed ID: 2416749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.
    Sugo T; Ohno Y; Shimada T; Kato H; Iwanaga S
    Adv Exp Med Biol; 1983; 156():87-107. PubMed ID: 6602465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced or unchanged cofactor function of human high molecular weight kininogen induced by human plasma kallikrein.
    Johansen HT; Briseid K
    Adv Exp Med Biol; 1986; 198 Pt A():147-53. PubMed ID: 3492869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of guinea-pig plasma prekallikrein. Activation by prekallikrein activator derived from guinea-pig skin.
    Yamamoto T; Kozono K; Okamoto T; Kato H; Kambara T
    Biochim Biophys Acta; 1980 Aug; 614(2):511-25. PubMed ID: 6967737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic studies on surface-mediated activation of bovine factor XII and prekallikrein. Effects of kaolin and high-Mr kininogen on the activation reactions.
    Sugo T; Kato H; Iwanaga S; Takada K; Sakakibara S
    Eur J Biochem; 1985 Jan; 146(1):43-50. PubMed ID: 3871394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A monoclonal anti-human plasma prekallikrein antibody that inhibits activation of prekallikrein by factor XIIa on a surface.
    Veloso D; Silver LD; Hahn S; Colman RW
    Blood; 1987 Oct; 70(4):1053-62. PubMed ID: 2443201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human plasma prekallikrein. Studies of its activation by activated factor XII and of its inactivation by diisopropyl phosphofluoridate.
    Bouma BN; Miles LA; Beretta G; Griffin JH
    Biochemistry; 1980 Mar; 19(6):1151-60. PubMed ID: 6768384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunochemical studies of plasma kallikrein.
    Bagdasarian A; Lahiri B; Talamo RC; Wong P; Colman RW
    J Clin Invest; 1974 Dec; 54(6):1444-54. PubMed ID: 4140197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An improved method of isolation of rat pancreatic prokallikrein. Characterization of the zymogen and of the kallikrein produced by trypsin activation.
    Hussain M; Bailey GS
    Biochim Biophys Acta; 1982 Oct; 719(1):40-6. PubMed ID: 6924592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of an inhibitor of factor XIIa from bovine plasma.
    Thornton RD; Kirby EP
    J Biol Chem; 1987 Sep; 262(26):12714-21. PubMed ID: 3114262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of beta-XIIa (Hageman factor fragment) from human plasma.
    Tankersley DL; Alving BM; Finlayson JS
    Thromb Res; 1982 Feb; 25(4):307-17. PubMed ID: 6978550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of prekallikrein from porcine plasma and its conversion to active kallikrein.
    Kikuno Y; Takahashi H; Suzuki T
    J Biochem; 1983 Jan; 93(1):235-41. PubMed ID: 6551387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prekallikrein activation and kallikrein inactivation in human plasma.
    van der Graaf F; Keus JF; Koedam JA; Rietveld A; Bouma BN
    Adv Exp Med Biol; 1983; 156():143-8. PubMed ID: 6190365
    [No Abstract]   [Full Text] [Related]  

  • 14. Kinetics of inhibition of human plasma kallikrein by a site-specific modified inhibitor Arg15-aprotinin: evaluation using a microplate system and comparison with other proteases.
    Scott CF; Wenzel HR; Tschesche HR; Colman RW
    Blood; 1987 May; 69(5):1431-6. PubMed ID: 2436687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of activation of prekallikrein by prekallikrein activator.
    Tankersley DL; Fournel MA; Schroeder DD
    Biochemistry; 1980 Jul; 19(14):3121-7. PubMed ID: 6967731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of a cationic fragment of high molecular mass kininogen and effect of this fragment on human plasma kallikrein activity.
    Yarovaya GA; Dotsenko VL; Orekhovich VN
    Clin Chim Acta; 1982 Aug; 123(3):261-7. PubMed ID: 6922013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of aprotinin and gabexate mesilate on human plasma kallikrein.
    Nakahara M
    Arzneimittelforschung; 1983; 33(7):969-71. PubMed ID: 6194800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on prekallikrein of bovine plasma. II. Activation of prekallikrein with proteinases and properties of kallikrein activated by bovine Hageman factor.
    Takahashi H; Nagasawa S; Suzuki T
    J Biochem; 1980 Jan; 87(1):23-34. PubMed ID: 6766924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of human urinary prokallikrein. Identification of the site of activation by the metalloproteinase thermolysin.
    Takada Y; Skidgel RA; Erdös EG
    Biochem J; 1985 Dec; 232(3):851-8. PubMed ID: 3937523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the effect of serine protease inhibitors on activated contact factors. Application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa.
    Tans G; Janssen-Claessen T; Rosing J; Griffin JH
    Eur J Biochem; 1987 May; 164(3):637-42. PubMed ID: 3552674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.